학술논문
Patient-reported outcomes from the phase III IMpassion130 trial of atezolizumab plus nab-paclitaxel in metastatic triple-negative breast cancer
Document Type
Article
Author
Source
In Annals of Oncology May 2020 31(5):582-589
Subject
Language
ISSN
0923-7534